Becker P - Search Results

1

A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.

Kushida CA, Walters AS, Becker P, Thein SG, Perkins AT, Roth T, Canafax D, Barrett RW; XP021 Study Group. Kushida CA, et al. Among authors: becker p. Sleep. 2009 Feb;32(2):159-68. doi: 10.1093/sleep/32.2.159. Sleep. 2009. PMID: 19238802 Free PMC article. Clinical Trial.

2

Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.

Allen R, Becker PM, Bogan R, Schmidt M, Kushida CA, Fry JM, Poceta JS, Winslow D. Allen R, et al. Sleep. 2004 Aug 1;27(5):907-14. doi: 10.1093/sleep/27.5.907. Sleep. 2004. PMID: 15453549 Clinical Trial.

3

Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.

Walters AS, Ondo WG, Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW; XP045 Study Group. Walters AS, et al. Clin Neuropharmacol. 2009 Nov-Dec;32(6):311-20. doi: 10.1097/WNF.0b013e3181b3ab16. Clin Neuropharmacol. 2009. PMID: 19667976 Clinical Trial.

4

Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.

Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW; XP052 Study Group. Kushida CA, et al. Among authors: becker pm. Neurology. 2009 Feb 3;72(5):439-46. doi: 10.1212/01.wnl.0000341770.91926.cc. Neurology. 2009. PMID: 19188575 Clinical Trial.

5

A 52-week study of gabapentin enacarbil in restless legs syndrome.

Ellenbogen AL, Thein SG, Winslow DH, Becker PM, Tolson JM, Lassauzet ML, Chen D. Ellenbogen AL, et al. Clin Neuropharmacol. 2011 Jan-Feb;34(1):8-16. doi: 10.1097/WNF.0b013e3182087d48. Clin Neuropharmacol. 2011. PMID: 21242741 Clinical Trial.

6

Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.

Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG; Medical Advisory Board of the Willis-Ekbom Disease Foundation. Silber MH, et al. Mayo Clin Proc. 2013 Sep;88(9):977-86. doi: 10.1016/j.mayocp.2013.06.016. Mayo Clin Proc. 2013. PMID: 24001490

7

Mood disorders in restless legs syndrome (Willis-Ekbom disease).

Becker PM, Sharon D. Becker PM, et al. J Clin Psychiatry. 2014 Jul;75(7):e679-94. doi: 10.4088/JCP.13r08692. J Clin Psychiatry. 2014. PMID: 25093484 Free article. Review.

8

The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome.

Silber MH, Becker PM, Buchfuhrer MJ, Earley CJ, Ondo WG, Walters AS, Winkelman JW; Scientific and Medical Advisory Board, Restless Legs Syndrome Foundation. Silber MH, et al. Mayo Clin Proc. 2018 Jan;93(1):59-67. doi: 10.1016/j.mayocp.2017.11.007. Mayo Clin Proc. 2018. PMID: 29304922

9

In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs Syndrome.

Silber MH, Becker PM, Buchfuhrer MJ, Earley CJ, Ondo WG, Walters AS, Winkelman JW. Silber MH, et al. Mayo Clin Proc. 2018 Jul;93(7):955-956. doi: 10.1016/j.mayocp.2018.03.021. Mayo Clin Proc. 2018. PMID: 29976378 No abstract available.

10

Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS.

Sharon D, Allen RP, Martinez-Martin P, Walters AS, Ferini Strambi L, Högl B, Trotti LM, Buchfuhrer M, Swieca J, Bogan RK, Zak R, Hensley JG, Schaefer LA, Marelli S, Zucconi M, Stefani A, Holzknecht E, Olvera V, Meaklim H, Laska I, Becker PM; International RLS Study Group. Sharon D, et al. Among authors: becker pm. Sleep Med. 2019 Feb;54:94-100. doi: 10.1016/j.sleep.2018.10.014. Epub 2018 Oct 29. Sleep Med. 2019. PMID: 30529783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,659 results

Search Page